Punicalagin (Ellagitannin · Antioxidant · Gut Health · Urolithin Precursor)

Compound	Punicalagin
Chemical class	Polyphenol — Ellagitannin (α and β anomers)
CAS	65995-63-3
Primary source	Punica granatum (pomegranate rind)
Key applications	Antioxidant, anti-inflammatory, gut health, urolithin precursor
Claim strength	Moderate
Typical form	Pomegranate extract standardised to punicalagin content (30–40%)
Buy from Herbuno	Pomegranate Extract Powder | Anar → Ellagic Acid 40% Powder (Pomegranate Extract) | Standardized Punica granatum →

Name origin: From Punica (pomegranate genus) — punicalagin is the signature ellagitannin of pomegranate, found predominantly in the rind (peel) rather than the edible arils. Punicalagin exists as two anomers (α and β) and is one of the largest naturally occurring polyphenols, with a molecular weight of approximately 1084 Da. Traditional use: Pomegranate rind preparations have been used in Ayurveda, traditional Arabic medicine, and TCM for dysentery, anthelmintic applications, wound healing, and as a general tonic. The rind (which is discarded in juice production) contains the highest punicalagin concentration and is the commercial extraction source. Research trajectory: Punicalagin has one of the highest ORAC values measured for any natural compound. It has documented bioavailability in humans (intact molecule detected in plasma), is an ellagic acid precursor (and thus urolithin precursor), and has dedicated research for cardiovascular, anti-inflammatory, and gut microbiome-modulating properties. Commercial source: Punicalagin is commercially available as a standardised pomegranate (Punica granatum) rind extract at 40% punicalagins by HPLC. See sourcing options below.

---

Evidence for Punicalagin Applications

Antioxidant — highest documented ORAC: Punicalagin has an exceptionally high ORAC value — pomegranate juice ORAC significantly exceeds red wine and green tea, primarily due to punicalagin content. Human supplementation studies with pomegranate extract consistently show increased plasma antioxidant capacity, reduced LDL oxidation, and reduced 8-OHdG (DNA oxidation marker). Claim strength: High (for pomegranate extract antioxidant; punicalagin as primary active well-supported).

Cardiovascular and anti-atherosclerotic: Human RCTs with pomegranate juice (punicalagin-rich) show reductions in carotid intima-media thickness (CIMT — a cardiovascular risk marker), reduced systolic blood pressure, and improved serum lipid profiles over 1–3 years. Anti-atherosclerotic mechanisms include LDL oxidation inhibition, macrophage foam cell reduction, and eNOS activation. Claim strength: Moderate.

Gut microbiome modulation: Punicalagin is a direct prebiotic — it selectively promotes growth of beneficial bacteria (Akkermansia muciniphila, Bifidobacterium) and suppresses pathogenic species in cell and animal models. This prebiotic activity is separate from its role as urolithin precursor. Human gut microbiome studies with pomegranate extract show shifts toward beneficial bacterial profiles. Claim strength: Moderate.

---

Dosage & Formulator Specification

Clinical studies using pomegranate preparations: 240 mL/day pomegranate juice (approximately 1–2 g total punicalagins) for cardiovascular and antioxidant applications. For Herbuno’s Punicalagins 40% extract: 250–500 mg/day delivers 100–200 mg punicalagins — a practical supplement dose. Cardiovascular CIMT studies used pomegranate preparations providing approximately 1.5 g/day total polyphenols.

Unlike ellagic acid (low oral bioavailability), punicalagin is partially absorbed intact — plasma punicalagin has been detected in human pharmacokinetic studies, though the predominant systemic exposure is via its hydrolysis products (ellagic acid) and subsequent urolithin formation. The intact tannin also exerts local effects in the GI tract relevant to gut microbiome modulation.

Specify punicalagins content by HPLC (30–40% in commercial pomegranate extract) alongside ellagic acid content. Total polyphenol content by Folin-Ciocalteu is a broader but less specific quality marker. Herbuno’s Punicalagins 40% extract is the higher-standardisation option for punicalagin-targeted formulations versus the general Pomegranate Extract Powder.

---

Frequently Asked Questions — Punicalagin

Is pomegranate juice as effective as pomegranate extract for punicalagins?
Pomegranate juice made with peel extraction contains high punicalagin levels; juice made from arils only contains very little (punicalagins are concentrated in the rind). Commercial pomegranate juices vary enormously in punicalagin content depending on production method. Standardised pomegranate extract (30–40% punicalagins) provides reliable dosing that is not achievable from commercial juice without knowing the specific product’s punicalagin content. For supplement formulation, standardised extract is the preferred vehicle.

Does punicalagin require gut bacteria to be effective?
Partially. Punicalagin’s local gut effects (prebiotic, anti-inflammatory in the GI tract) and some antioxidant activity occur without microbial conversion. For systemic effects mediated by urolithins, gut microbial conversion is required — and is limited to urolithin producers (~30–50% of individuals). Pre-formed urolithin A supplementation bypasses this limitation for systemic effects.

What is the difference between punicalagin and pomegranate extract?
Punicalagin is a specific ellagitannin molecule that is the primary polyphenol in pomegranate rind. Pomegranate extract is the broader term for extracts from pomegranate containing punicalagins alongside ellagic acid, anthocyanins (delphinidin, cyanidin, pelargonidin glycosides), and other polyphenols. Pomegranate extract standardised to 40% punicalagins is the most relevant specification for capturing the full ellagitannin bioactivity of the fruit.

Can punicalagin be combined with probiotic strains for synbiotic gut health formulations?
Yes — this is a rational synbiotic approach. Punicalagin selectively promotes Akkermansia muciniphila and Bifidobacterium (acting as a prebiotic), while Lactobacillus and Bifidobacterium probiotic strains provide direct microbiome reinforcement. The combination addresses both prebiotic substrate provision and direct microbial population support, consistent with a comprehensive gut microbiome health formulation strategy.

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery